fascioscapulohumeral dystrophy. J Bone Joint Surg 1978;60B: Non-Hodgkin's lymphoma complicating chronic pyothorax Rajni Amin FRCP FRCR J R Soc Med 1999; 92:89-90 Non-Hodgkin's lymphoma complicating chronic pyothorax is a rare event, and most reported cases are from the Far Eastl,2. Of the few cases reported in western countries none has been from the UK.
CASE HISTORY
A British-born man aged 58 was referred in July 1980 with a slowly enlarging painful lump on his right upper anterior chest wall. Since an episode of pleurisy and pneumonia at the age of 23, he had had a chronic pyothorax. At clinical assessment, there was a 15 x 10 cm mass, partly solid and partly cystic, and fixed to the right upper chest well. On auscultation there was practically no air entry on the right side but the rest of the examination was normal. His chest X-ray showed a large soft tissue mass, partly extrapleural and related to the right chest wall, without evidence of underlying bone destruction. There was widespread pleural thickening associated with pleural calcification. On the left side spotted calcification was noted basally with further evidence of pleural thickening and an old fracture of the left ninth rib (Figure 1 ). He was thought to have empyema necessitans so an attempt was made to drain the chest. Copious purulent material was removed with necrotic tissue which on histological examination showed a noncohesive infiltrate of bizarre malignant cells with many mitoses. The lesion was judged most likely to be a high grade non-Hodgkin's lymphoma. Immunocytochemistry was in its infancy in 1980 but the tumour has recently been reinvestigated and found positive for leucocyte common antigen (CD 45) and B-cell lineage markers (CD 20, CD 79a) ( (immunoperoxidase x 800) were normal. He was started on antituberculosis therapy and since there was no suggestion of systemic involvement by the lymphoma, received local radiotherapy for the lymphoma mass on a 4Mv linear accelerator (via a pair of wedged fields, mid-plane dose 47.50 Gy in 22 fractions over 35 days).
At 2-year follow-up the mass had completely resolved. He then remained well till March 1998, when there was no evidence of lymphoma recurrence but a routine chest X-ray showed a mass above the left hilum confirmed by computed tomography. Being symptom-free he was reluctant to undergo further investigations and treatment. Nine months later he reported cough, shortness of breath and haemoptysis, and a chest X-ray showed further enlargement of the mass above the left hilum. Again he refused further investigations. A panel of clinicians and radiologists judged the mass to be a bronchial neoplasm rather than a recurrent lymphoma-especially in view of the known increased risk of non-oat-cell carcinoma after treatment of non-Hodgkin's lymphoma. Since the symptoms were getting worse he agreed to palliative radiotherapy, which gave relief for six months, after which he did not attend for follow-up. Death, in August 1989, was certified due to carcinomatosis from carcinoma of the lung; no necropsy was done. COMMENT Non-Hodgkin's lymphoma develops in about 2.2% of patients with pyothorax. Epidemiological studies in Japan have suggested that the risk of lymphoma in this group is 3000 times greater than that in the general population3. The pathophysiology is not clear. The tumour develops several decades after the original infection and luchi et al.1 postulate chronic inflammatory stimulation, either autoimmune or non-autoimmune, as a factor. A causal role for Epstein-Barr virus in the development of pleural non-Hodgkin's lymphoma is supported by identification of EBV gene products in B lymphocytes from pyothorax-associated non-Hodgkin's lymphoma3. Lymphoma complicating pyothorax is usually of B cell origin. Most cases have been described from Japan. So far only eight cases of non-Hodgkin's lymphoma complicating pyothorax have been reported in western countries4, and ours is the first from the UK.
